论文部分内容阅读
应用小剂量尿激酶与低分子肝素钙联合治疗进展性脑梗死的疗效明显优于单纯应用尿激酶组,且副作用小,值得临床推广应用。
Application of low-dose combination of low-dose urokinase and low molecular weight heparin treatment of progressive cerebral infarction was significantly better than the simple application of urokinase group, and the side effects of small, worthy of clinical application.